| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |